Document Classification

Section Type: METHODS

Text: Patients were randomly assigned to paclitaxel 135 mg/m (2) over 24 hours plus Cis 50 mg/m (2) day 2 every 3 weeks (PC, reference arm) ; vinorelbine 30 mg/m (2) days 1 and 8 plus Cis 50 mg/m (2) day 1 every 3 weeks (VC) ; gemcitabine 1, 000 mg/m (2) day 1 and 8 plus Cis 50 mg/m (2) day 1 every 3 weeks (GC) ; or topotecan 0. 75 mg/m (2) days 1, 2, and 3 plus Cis 50 mg/m (2) day 1 every 3 weeks (TC).